4.43
전일 마감가:
$4.62
열려 있는:
$4.7
하루 거래량:
77,406
Relative Volume:
1.52
시가총액:
$208.95M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-11.22%
1개월 성능:
+3.75%
6개월 성능:
+0.00%
1년 성능:
+0.00%
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
명칭
Zhengye Biotechnology Holding Ltd
전화
-
주소
-
ZYBT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ZYBT
Zhengye Biotechnology Holding Ltd
|
4.43 | 208.95M | 0 | 0 | 0 | 0.00 |
![]()
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Zhengye Biotechnology Holding Ltd 주식(ZYBT)의 최신 뉴스
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - Renaissance Capital
Zhengye Biotechnology Holding Ltd (ZYBT) 재무 분석
Zhengye Biotechnology Holding Ltd (ZYBT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):